Kuala lumpur: Malaysia's initial public offering (IPO) market has once again asserted its leadership in Southeast Asia during the first half of 2026, maintaining its position as the regional frontrunner in terms of total IPO funds raised and the number of IPOs.
According to BERNAMA News Agency, the Deloitte Southeast Asia Mid-Year IPO Snapshot 2026 revealed that Malaysia successfully held its top-performing status for two consecutive first-half periods. A significant contributor to this achievement was Sunway Healthcare Holdings Bhd, which raised an impressive US$707 million, reaching a market capitalisation of US$4.13 billion in 1H 2026.
Wong Kar Choon, the capital markets services partner for Malaysia, noted that the fundraising value has shown resilience, indicating a shift towards larger and high-quality deals. He stated, "Overall, the Malaysian IPO market in 1H 2026 is healthy and maturing, transitioning from a volume-driven surge in 2025 to a more balanced, quality-focused growth phase."
Wong further highlighted that the IPO outlook in Malaysia is expected to remain positive for the remainder of 2026, with more than 40 potential listings anticipated in the pipeline.
In a regional context, Singapore has surpassed Indonesia in the Southeast Asia IPO rankings, reflecting growing investor confidence and a strong endorsement of its market reforms. Vietnam, on the other hand, has made a remarkable comeback from zero IPOs in the first half of 2025 to four IPOs in 1H 2026, with the highest IPO market capitalisation at US$6.92 billion.
The report from Deloitte indicated that the Southeast Asia IPO capital market witnessed 47 IPOs in 1H 2026, raising over US$3.07 billion in proceeds, with a market capitalisation of US$15.07 billion. This is a notable improvement compared to 1H 2025, which saw 53 IPOs with proceeds of US$1.41 billion and a market capitalisation of US$7.70 billion. Despite an 11 per cent decrease in the number of IPOs across the region, the amount raised and market capitalisation increased by 117 per cent and 96 per cent, respectively.
The average IPO deal size also saw a significant rise, being 2.4 times that of 1H 2025, growing from US$26 million to US$65 million. The Southeast Asia IPO capital market is reportedly moving towards prioritising quality over quantity, registering three blockbuster IPOs in the first half of 2026.
These three high-profile IPOs, each raising over US$500 million, include UI Boustead REIT (Singapore), Sunway Healthcare Holdings Bhd (Malaysia), and Dien May Xanh Investment Joint Stock (Vietnam), collectively amassing an IPO market capitalisation of US$8.93 billion.
Looking ahead, Deloitte anticipates the Southeast Asia IPO market will continue to thrive, driven by a robust pipeline, improving investor sentiment, and easing interest rate conditions. The market is expected to lean towards fewer but larger, high-quality deals. Malaysia is poised to sustain its IPO activity, while Singapore is likely to continue its appeal to large institutional listings.